Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Vitamin D Deficiency 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Polycystic Ovary Syndrome 2Neoplasms 1Multiple Sclerosis, Relapsing-Remitting 1Giant Cell Tumor of Bone 1Gastrointestinal Neoplasms 1Cognitive Dysfunction 1Cholangiocarcinoma 1Carcinoma, Ovarian Epithelial 1Carcinoma, Hepatocellular 1Cachexia 1

Interventions

Neuropsychological Tests 2Vitamin D 1Standard of Care 1Silymarin 1Physical Conditioning, Human 1Patient Reported Outcome Measures 1Mindfulness 1Geriatric Assessment 1Exergaming 1Counseling 1Coping Skills 1Cognitive Training 1Blood Specimen Collection 1Aspirin 1Ashwagandha 1Anticonvulsants 1Absorptiometry, Photon 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Cognitive Dysfunction × Vitamin D × Clear all
NCT05552729 2022-09-23

Effects of Different Doses of Vitamin D on Cancer-related Cognitive Impairment in Patients With Gastrointestinal Tumors

Yangzhou University

Phase 1/2 Unknown
114 enrolled
Gastrointestinal

Gastrointestinal Neoplasms, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡